A Comparison of Speech Outcome in Pediatric Cleft Patients, After Modified Furlow-Sommerlad Palatoplasty in Comparison to Modified Furlow Palatoplasty Alone

Cleft Palate Children Clinical Trial

— SPEAC  

Official title:

A Comparison of Speech Outcome in Pediatric Cleft Patients, After Modified Furlow Palatoplasty in Combination With Intravelar Veloplasty According to Sommerlad, or Modified Furlow Palatoplasty Alone

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03995199
• Other study ID #: B049201629483
• Status: Recruiting
• Start date: September 13, 2017
• Est. completion date: December 31, 2025

Study information

• Verified date: February 2022
• Source: AZ Sint-Jan AV
• Contact: Araceli Diez-Fraile
• Phone: +32 5045 9660
• Email: araceli.diez-fraile[@]azsintjan.be
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Nowadays, surgical success of cleft palate patients is ascribed to the sufficiency of velopharyngeal closure, and the associated speech results such as voice nasality, resonance and articulation. The investigators aim to evaluate if the surgical modified Furlow palatoplasty in combination with the intravelar veloplasty according to Sommerlad significantly reduces the number of pediatric patients with abnormal speech between five and seven years of age, as measured with the four-point scale recently published by Nguyen et al.(2015), in comparison to the conventional modified Furlow technique.

study design A prospective cohort trial. All cleft palate patients surgically treated with a modified Furlow technique since January 2012 or a modified Furlow technique in combination with an intravelar veloplasty by Sommerlad routinely undergo an annual speech evaluation by the speech language pathologist of the cleft team. At the age of five, eligible patients that are in continuous follow-up by the cleft team at our hospital, will be asked for consent to register their demographic, surgical and speech-related data. In addition, the parents of cleft patients will be asked to complete a quality of life questionnaire concerning their child, at the time of speech evaluation through self-report or through an interview with the clinical research coordinator.

The investigators hypothesise that the combined modified Furlow and Sommerlad palatoplasty leads to a minimal 50% reduction in the proportion of children with abnormal speech, as defined by the four-point scale recently published by Nguyen et al.(2015), compared to patients that underwent a Modified Furlow technique alone.

conclusion Although the technique by Sommerlad has shown promising results, prospective trials comparing postoperative speech outcome after different surgical techniques, are lacking. The present trial could offer objective results to validate the current surgical treatment protocol implemented at our department.

Description:

Nowadays, surgical success of cleft palate patients is ascribed to the sufficiency of velopharyngeal closure, and the associated speech results such as voice nasality, resonance and articulation. The investigators aim to evaluate if the surgical modified Furlow palatoplasty in combination with the intravelar veloplasty according to Sommerlad significantly reduces the number of pediatric patients with abnormal speech between five and seven years of age, as measured with the four-point scale recently published by Nguyen et al.(2015), in comparison to the conventional modified Furlow technique.

study design A prospective cohort trial. All cleft palate patients surgically treated with a modified Furlow technique since January 2012 or a modified Furlow technique in combination with an intravelar veloplasty by Sommerlad routinely undergo an annual speech evaluation by the speech language pathologist of the cleft team. At the age of five, eligible patients that are in continuous follow-up by the cleft team at our hospital, will be asked for consent to register their demographic, surgical and speech-related data. In addition, the parents of cleft patients will be asked to complete a quality of life questionnaire concerning their child, at the time of speech evaluation through self-report or through an interview with the clinical research coordinator.

The investigators hypothesise that the combined modified Furlow and Sommerlad palatoplasty leads to a minimal 50% reduction in the proportion of children with abnormal speech, as defined by the four-point scale recently published by Nguyen et al.(2015), compared to patients that underwent a Modified Furlow technique alone.

conclusion Although the technique by Sommerlad has shown promising results, prospective trials comparing postoperative speech outcome after different surgical techniques, are lacking. The present trial could offer objective results to validate the current surgical treatment protocol implemented at our department.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: December 31, 2025
• Est. primary completion date: January 1, 2025
• Gender: All
• Age group: 5 Years to 7 Years

Eligibility

Inclusion Criteria:

• Patients should have a clinically diagnosed cleft of the hard and/or soft palatum, with or without involvement of the lip or nose (Veau classification I to IV (see Appendix 1).

• Patients should have undergone a modified Furlow palatoplasty or modified Furlow according to Sommerlad in the AZ Sint-Jan Brugge-Oostende av

• Patients should receive their postoperative care and speech therapy by the cleft team of the general hospital Sint-Jan Bruges

• Patients should be in the fifth life year at time of speech evaluation

• Patients should be Dutch-speaking as a maternal language

Exclusion Criteria:

• Patients not meeting the abovementioned inclusion criteria

• Patients that received a corrective surgical procedure for velopharyngeal dysfunction after the modified Furlow technique alone, or in combination with the intravelar veloplasty by Sommerlad

• Patients that are bi- or multilingual

• Patients with clinically diagnosed mild hearing difficulties (i.e. ASHA classification: hearing loss >25dB)30

• Patients with a clinically diagnosed stutter

• Patients with clinically diagnosed cognitive and/or motoric disabilities

• Patients that received intensive speech therapy prior to their fifth life year can be included, but will be analyzed separately(subgroup analysis)

• Note: The number of patients with a uni- or bilateral cleft involving the lip or nose should be comparable between both groups, since this can interfere with speech and could bias comparison of speech outcome between different cleft subgroups.

Related Conditions & MeSH terms

• Cleft Palate
• Cleft Palate Children

Locations

Country	Name	City	State
Belgium	Division of oral and maxillofacial surgery, Department of Surgery, AZ Sint-Jan Brugge-Oostende AV	Brugge

Sponsors (1)

Lead Sponsor	Collaborator
AZ Sint-Jan AV

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	proportion of children with abnormal speech, as defined by the four-point scale recently published by Nguyen et al.(2015)	proportion of children with abnormal speech, as defined by the four-point scale recently published by Nguyen et al.(2015)	at time of routine speech evaluation between age 5-7 years old
Secondary	prevalence of speech problems, as defined by the perceptual evaluation	prevalence of speech problems, as defined by the perceptual evaluation	at time of routine speech evaluation between age 5-7 years old
Secondary	prevalence of speech problems, as defined by the objective speech evaluation (nasometry)	prevalence of speech problems, as defined by the objective speech evaluation (nasometry)	at time of routine speech evaluation between age 5-7 years old
Secondary	incidence of 30-day postoperative complications	incidence of 30-day postoperative complications	within 30 days postoperative
Secondary	PVRQOL questionnaire, as a measure of quality of life	PVRQOL questionnaire, as a measure of quality of life	at time of routine speech evaluation between age 5-7 years old
Secondary	COHIP questionnaire, as a measure of quality of life	COHIP questionnaire, as a measure of quality of life	at time of routine speech evaluation between age 5-7 years old